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ORIGINAL ARTICLE
Background/Aims: Acute kidney injury (AKI) is a common and serious complication in critically ill patients,
especially in the intensive care unit (ICU). The present study was performed to evaluate the occurrence rate of
AKI using the RIFLE (increasing severity classes risk, injury, and failure, and the two outcome classes loss and
end-stage kidney disease) classification, to define factors associated with AKI and hospital mortality.
Methods: We performed a retrospective study of all ICU patients over a 6-month period at Keimyung University
Dongsan Hospital, Daegu, Korea. AKI was evaluated according to the RIFLE classification.  
Results: AKI occurred in 156 of the 378 patients (41.3%) during their ICU stay, with maximum RIFLE-R, I, and
F in 13.8%, 12.4%, and 15.1%, respectively. In univariate analysis, the proportion of medical admission and
maximum Sequential Organ Failure Assessment (SOFA) score (SOFAmax) were significantly higher in patients
with AKI than in those without. However, these factors did not remain significant in a multivariate analysis. The
overall mortality rate of ICU patients was 25.7%. In multivariate analysis, mean age, occurrence of AKI,
SOFAmax score, pulmonary disease, and malignancy were independent risk factors for hospital mortality. 
Conclusions: In these ICU patients, AKI is associated with increased hospital mortality. The RIFLE classification
is a simple and useful clinical tool to detect and stratify the severity of AKI, and may aid in the prediction of
outcome. (Korean J Intern Med 2010;25:181-187)
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INTRODUCTION
Acute kidney injury (AKI) is a common and serious
complication in critically ill patients. The mortality rate in
AKI patients remains high despite significant advances in
medical care [1-4]. Recently, the Acute Dialysis Quality
Initiative (ADQI) work group, comprised of experts in the
fields of nephrology and critical care medicine, proposed
a multilevel classification system for AKI, the “RIFLE”
classification [5], which stands for the increasing severity
classes Risk, Injury, and Failure, and the two outcome
classes Loss and End-stage kidney disease (Fig. 1).
Several studies have shown the RIFLE classification to be
a simple, readily available clinical tool to classify acute
kidney injury in different populations [6].
In addition to the RIFLE classification, several instru-
ments for scoring illness severity, such as the Sequential
Organ Failure Assessment (SOFA), Acute Physiology And
Chronic Health Evaluation (APACHE) II and III, and
Simplified Acute Physiology Score (SAPS) II, are widely
used in critically ill patients; they weigh kidney dysfunction
variously [2]. Among these scoring systems, the SOFA
score may be used to describe the time course of organ
dysfunction in individual patients and is useful to evaluate
morbidity [7].
Risk factors associated with hospital mortality in
critically ill patients with AKI have been evaluated in
several studies. The main risk factors identified were
advanced age, use of vasopressors, mechanical ventilation,
septic shock, hepatorenal syndrome, and cardiogenicshock [6,8].
The present study was performed to apply the RIFLE
classification to patients in intensive care units (ICUs), to
identify risk factors related to the development of AKI,
and factors associated with hospital mortality in ICU
patients.
METHODS
Study population
We constructed a retrospective study of all ICU patients
over a 6-month period (July 1, 2007 to December 31,
2007) at the Keimyung University Dongsan Hospital,
Daegu, Korea. During the study period, in total, 1,280
patients were admitted to the ICU and the records of all
patients were reviewed. We excluded patients who remained
in the ICU for less than 48 hours, those readmitted to the
ICUs, those admitted after an uncomplicated operation,
and those with a history of chronic renal failure requiring
renal replacement therapy.
Data collection
Demographic and laboratory data were retrieved from
an electronic hospital database. In total, 378 patients were
included. After merging data from the different sources,
we performed automated and manual data verification.
Patient data included demographic, administrative,
physiological, laboratory, and hospital outcome information.
RIFLE classification
All patients included in the study were classified
according to the highest RIFLE criteria during the first 7
days in the ICU. Patients who presented with neither
oliguria nor marked increases in serum creatinine were
included in the non-AKI group. When baseline serum
creatinine level was unknown in a patient with no history
of chronic kidney insufficiency, we calculated the baseline
creatinine using the modification of diet in renal disease
(MDRD) equation, as recommended by the ADQI, assuming
a glomerular filtration rate of 75 mL/min / 1.73 m2[5,9].
SOFA score
Organ failure was defined by the SOFA score, based on
six different scores, one for each of the respiratory,
cardiovascular, hepatic, coagulation, renal, and neurological
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Table 1. SOFA score
SOFA score 0 1 2 3 4
Respiration PaO2 / FiO2 mmHg > 400 ≤ 400 ≤ 300 ≤ 200 ≤ 100
Coagulation, Platelets ×103/mm3 > 150 ≤ 150 ≤ 100 ≤ 50 ≤ 20
Liver bilirubin, mg/dL < 1.2 1.2 - 1.9 2.0 - 5.9 6.0 - 11.9 >12.0
Cardiovascular hypotension No MAP < 70 mmHg Dopamine ≤ 5 or Dopamine ≤ 5 or Dopamine ≤ 5 or
Dobutamine (any dose)a Epinephrine ≤ 1 or Epinephrine ≤ 1 or
Norepiephrine ≤ 0.1a Norepiephrine ≤ 0.1a
Central nervous system  15 13 ± 14 10 - 12 6 - 9 < 6
Glasgow coma scale, score
Renal creatininin, mg/dL or  < 1.2 1.2 - 1.9 2.0 - 3.4 3.5 - 4.9 or  > 5.0 or
urine output, mL/day < 500 < 200
SOFA, sequential organ failure assessment; MAP, mean arterial pressure. 
aAdrenergic agents administered for at least 1 hr (doses given in µg/kg•min).
Figure 1. The risk, injury, failure, and the two outcome classes
loss and end-stage kidney disease (RIFLE) classification separates
criteria for serum creatinine and urine output. GFR, glomerular
filtration rate; UO, urine output; ARF, acute renal failure.systems (Table 1) [10]. We observed the changes in SOFA
score every 24 hours during the first 7 days in the ICU.
The worst values for each parameter in any 24-hour
period were recorded.
Statistical analyses
Data were analyzed using the SPSS version 12.0 (SPSS
Inc., Chicago, IL, USA). Categorical data are expressed as
proportions, and subgroups were analyzed using the χ2
test. Risk factors were evaluated by univariate analysis
and in a multivariate analysis with a multiple logistic
stepwise regression procedure. The relationships between
different factors and mortality were evaluated using a Cox
Proportional Hazards model, and survival curves were
constructed. Variables with p < 0.05 were included in the
model. Odds ratios were estimated form the b coefficients
obtained, with respective 95% confidence intervals. In all
comparisons, p values < 0.05 were deemed to indicate
statistical significance.
RESULTS
Patient baseline characteristics
Patient baseline characteristic are summarized in Table
2. In total, 378 patients were included in this study. The
mean age of the patients was 62.6 ± 15.9 years and they
comprised 237 men (62.7%) and 141 women (37.3%).
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Table 2. Patient baseline characteristics
Characteristics Value
Number of patients 378
Mean age, yr 62.6 ± 15.9
Males 237 (62.6)
Medical admission 312 (82.5)
Reason for admission
Pulmonary disease 85 (22.4)
Gastrointestinal disease 75 (19.8)
Cardiovascular disease 41 (10.8)
Malignancy 59 (15.6)
Infection 41 (10.8)
Neurological disease 34 (8.9)
Trauma 25 (6.6)
Others 19 (4.9)
Baseline serum creatinine, mg/dL 1.1 ± 0.7
SOFAmax score 7.4 ± 4.3
Hospital stay, day (range) 17.2 ± 17.2 (2 to 155)
Hospital mortality   97 (25.7)
Values are presented as number (%) or mean ± SD.
SOFAmax, maximum sequential organ failure assessment.
Table 3. Baseline characteristics of patients classified according to RIFLE criteria
Non-AKI
AKI
(n = 222) All Risk Injury Failure p value
(n = 156) (n = 52) (n = 47) (n = 57)
Mean age, yr 62.9 ± 16.5 62.3 ± 14.9 62.5 ± 16.2 65.7 ± 12.4 59.3 ± 15.3 NS
Males  140 (63) 97 (62.2) 33 (63) 27 (57) 37 (65) NS
Medical admission  172 (77) 140 (89.7) 48 (92) 42 (89) 50 (87) 0.015
Reason for admission
Pulmonary disease 55 (24.8) 30 (19.2) 10 (19.2) 11 (23.4) 9 (15.8) NS
Gastrointestinal disease 47 (21.2) 28 (17.9) 7 (13.5) 9 (19.1) 12 (21.1) NS
Cardiovascular disease 20 (9.0) 21 (13.5) 9 (17.3) 8 (17.0) 4 (7.0) NS
Malignancy 30 (13.5) 29 (18.6) 10 (19.2) 5 (10.6) 14 (24.6) NS
Infection 18 (8.1) 23 (14.7) 7 (13.5) 6 (12.8) 10 (17.5) NS
Neurological disease 23 (10.4) 11 (7.1) 4 (7.7) 4 (8.5) 3 (5.3) NS
Trauma 19 (8.6) 6 (3.8) 2 (3.8) 1 (2.1) 3 (5.3) NS
Others  10 (4.5) 9 (5.8) 4 (7.6) 3 (6.3) 2 (3.5) NS
Hospital stay, day 16.5 ± 16.1 18.3 ± 18.6 16.5 ± 16.0 20.0 ± 22.5 18.7 ± 17.5 NS
SOFAmax score 6.1 ± 3.6 9.3 ± 9.8 8.7 ± 4.2 8.4 ± 4.6 10.5 ± 4.1 0.000
Values are presented as number (%) or mean ± SD.
Tested by one-way analysis of variance among groups.
RIFLE, risk, injury, failure, and the two outcome classes loss and end-stage kidney disease; AKI, acute kidney injury; NS, not
significant; SOFAmax, maximum sequential organ failure assessment.Regarding the type of ICU admission, 312 (82.5%) cases
were medical admissions. Reasons for admission to
the ICU included pulmonary disease (n = 85, 22.4%),
gastrointestinal disease (n = 75, 19.8%), cardiovascular
disease (n = 41, 10.8%), malignancy (n = 59, 15.6%),
infection (n = 41, 10.8%), neurological disease (n = 34,
8.9%), trauma (n = 25, 6.6%), endocrinological disease (n
= 13, 3.4%), acute intoxication (n = 5, 1.3%), and obstetric
and gynecological disease (n = 1, 0.2%). The baseline
serum creatinine level was 1.1 ± 0.7 mg/dL, and the mean
SOFAmax score was 7.4 ± 4.3. The mean length of hospital
stay was 17.2 ± 17.2 days (range, 2 to 155) and the overall
hospital mortality rate of the ICU patients was 25.7%.
Comparison of patient characteristics according
to the RIFLE classification
The AKI and non-AKI groups consisted of 156 cases
(41.3%) and 222 cases (58.7%), respectively. The AKI
group was also classified according to RIFLE as follows:
risk (n = 52, 13.8%), injury (n = 47, 12.4%), and failure
(n = 57, 15.1%). The mean age, gender, reason for admission,
and length of hospital stay were not significantly different
between the four groups. However, the proportion of
medical admissions was significantly higher in the AKI
group than in the non-AKI group. The SOFAmax score
during the first week after admission was significantly
higher in the AKI group than in the non-AKI group (Table
3). However, in a multivariate analysis, neither medical
admission nor SOFAmax score were independent risk
factors for the occurrence of AKI.
Hospital mortality and survival rates
The overall mortality among patients studied was 25.7%
(97 / 378). The hospital mortality rate was 19% for non-
AKI patients, 29% for risk patients, 36% for injury
patients, and 51% for failure patients (p < 0.005, Fig. 2).
Cumulative survival rates differed significantly for non-
AKI versus AKI patients (p < 0.001, Fig. 3). Patients with
risk, injury, and failure had 90-day cumulative survival
rates of 56.6%, 47.0%, and 25.2%, respectively, compared
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Figure 2. Hospital mortality rates for intensive care unit
(ICU) patients without acute kidney injury and ICU patients
with increasing risk, injury, failure, and the two outcome
classes loss and end-stage kidney disease (RIFLE) criteria. ap <
0.005, tested by oneway analysis of variance among groups.
AKI, acute kidney injury.
Figure 3. Hospital survival. Cumulative survival rates differed
significantly for non-AKI versus AKI patients. p<0.001, tested
by Log rank test. AKI, acute kidney injury.
Figure 4. Hospital survival rate based on risk, injury, failure,
and the two outcome classes loss and end-stage kidney disease
(RIFLE) classification. There were a progressive and significant
decrease in cumulative survival rate associated with increasing
RIFLE classification among all patients. p < 0.001, tested by Log
rank test. AKI, acute kidney injury.with 68.5% for non-AKI patients. There was a progressive
and significant decrease in cumulative survival rate
associated with increasing RIFLE classification among all
patients (p< 0.001, Fig. 4).
Factors associated with hospital mortality
Non-survivors were older than survivors (65.8 ± 12.7
vs. 61.5 ± 16.6 years, respectively, p = 0.008) and more
commonly developed AKI during the ICU stay (62.9% vs.
33.8%, respectively; p < 0.001). The SOFAmax score was
significantly higher in non-survivors than in survivors
(10.7 ± 4.0 vs. 6.2 ± 3.6, respectively; p < 0.001). The
proportions of medical admission, pulmonary disease,
and malignancy as reasons for admission were
significantly higher in non-survivors than in survivors.
However, the proportions of gastrointestinal disease,
cardiovascular disease, and trauma were significantly
lower in non-survivors than in survivors. Neither length of
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Table 4. Univariate analysis of risk for hospital mortality 
Survivors Non-survivors
p value
(n = 281) (n = 97)
Mean age, yr 61.5 ± 16.6 65.8 ± 12.7 0.008
Males 180 (64.1) 57 (58.8) 0.394
Acute kidney injury 95 (33.8) 61 (62.9) 0.000
Risk 37 (13.2) 15 (15.5) NS
Injury 30 (10.7) 17 (17.5) NS
Failure 28 (10.0) 29 (21.9) 0.000
Medical admission  224 (79.7) 88 (90.7) 0.013
Reason for admission
Pulmonary disease  54 (19.2) 31 (32.0) 0.011
Gastrointestinal disease 65 (23.1) 10 (10.3) 0.007
Cardiovascular disease  36 (12.8) 5 (5.2) 0.038
Malignancy  29 (10.3) 30 (30.9) 0.000
Infection  33 (11.7) 8 (8.2) NS
Neurological disease  25 (8.9) 9 (9.3) NS
Trauma 23  (8.2) 2  (2.1) 0.034
Hospital stay, day 17.8 ± 15.8 15.2 ± 20.6 0.201
SOFAmax score 6.2 ± 3.6 10.7 ± 4.0 0.000
Values are presented as number (%) or mean ± SD.
NS, not significant; SOFAmax, maximum sequential organ failure assessment.
Table 5. Multivariate analysis of risk for hospital mortality
Odds ratio  
95% Confidence interval
p value
Lower Upper
Mean age 1.026 1.004 1.049 0.021
Acute kidney injury  1.499 1.167 1.924 0.001
Medical admission 1.555 0.590 4.098 NS
Reason for admission 
Pulmonary disease 2.532 1.140 5.624 0.023
Gastrointestinal disease 0.698 0.262 1.864 NS
Cardiovascular disease 0.705 0.223 2.230  NS
Malignancy 4.173 1.800 9.673 0.001
Trauma 0.461 0.079 2.706 NS
SOFAmax score  1.282 1.186 1.386 0.000
NS, not significant; SOFAmax, maximum sequential organ failure assessment.hospital stay nor gender was significantly different
between survivors and non-survivors (Table 4).
In the multivariate analysis, increasing age, occurrence
of AKI, increasing SOFA score, pulmonary disease, and
malignancy were independent risk factors for hospital
mortality (Table 5).
DISCUSSION
We conducted a single-center study with 378 ICU
patients to characterize AKI, defined by RIFLE classi-
fication, and related this classification to mortality in
critically ill patients. In the present study, 41.3% of the
ICU patients developed AKI, which was associated with
increased mortality, compared with those who did not
develop AKI. Hoste et al. [2] reported that AKI occurred in
67% of ICU patients, with maximum RIFLE classes of
risk, injury, and failure in 12%, 27%, and 28% of cases,
respectively. The incidence of almost 70% may appear
inconsistent with the existing literature [5,11-13]. The
incidence of AKI in the present study was somewhat lower
than those in other studies [2,14] using the same RIFLE
classification. The most likely explanations are differences
in the patient case mix, factors related to a single-center
versus multicenter study, and differences in the type of
admission (i.e., medical vs. surgical). Hoste et al. [2]
suggested that medical admission was less likely to result
in AKI, compared with surgical admission [4]. Medical
admission accounted for less than 50% of cases in a
multicenter cohort study of AKI [4], and the rate was
about 78% in a single-center cohort study [14]. In the
present study, medical admission accounted for the
majority of ICU patients. Hoste et al. [2] reported that
increasing age, greater severity of illness (APACHE III,
SOFA), preexisting chronic kidney insufficiency, and
previous admission to a non-ICU ward were associated
with significant mortality rates, ranging from 20% to 80%,
and associated with increased risk for the occurrence of
AKI.
Importantly, even a mild degree of kidney dysfunction,
RIFLE class risk or injury, was associated with elevated
mortality rate, compared with patients who maintained
normal function. In the present study, the overall hospital
mortality rate of ICU patients was 25.7%, which was
significantly higher for AKI patients versus non-AKI
patients. We also found that ICU mortality ranged from
29% in risk patients, 36% in injury patients, and 51% in
failure patients. Factors associated with mortality in our
ICU patients included advanced age, development of AKI,
baseline severity of illness, and the presence of pulmonary
disease and malignancy. These findings were consistent
with previous reports [2,3,15]. Hoste et al. [2] demonstrated
the association of AKI with increased hospital mortality in
a general ICU population and demonstrated that there
was increasing mortality risk over RIFLE classes, although
these ICU patients had similar comorbidity rates, as
reflected by non-renal SOFA scores. They also proposed
that the pathophysiological changes resulting from kidney
insufficiency and adverse effects of renal replacement
treatment may be associated with increased mortality rate
[2,16,17]. Uchino et al. [3] reported that there was an almost
linear increase in hospital mortality rate with increasing
RIFLE class, with patients in the risk group having a
mortality rate more than three times higher than that of
patients without AKI. In multivariate analysis, the risk
group showed an odds ratio of hospital mortality of 2.5,
that of the injury group was 5.4, and that of the failure
group was 10.1 [3]. They suggested that the development
of AKI has greater prognostic implications than the need
for ICU or mechanical ventilation, and the development of
failure is one of the most powerful identifiable outcome
predictors for hospitalized patients [3]. Abosaif et al. [18]
also reported that ICU mortality rate increased from
38.3% among patients in the risk group to 50% in the
injury group and to 74.5% among patients in the failure
group. Our study confirmed that even a mild degree of
kidney dysfunction posed a significant risk of hospital
mortality.
This study has some limitations. First, it was a retro-
spective study using existing medical records, which in
itself caused some difficulty in the assessment of AKI and
the statistical analyses. Second, we classified patients
according to the highest RIFLE criteria during the first 7
days in the ICU, similar to the study reported previously
by Hoste et al. [2]. More recently, the Acute Kidney Injury
Network (AKIN) group proposed refinements to the
RIFLE classification [13]. In particular, the AKIN group
sought to increase the sensitivity of the RIFLE classification
by setting a 48-hour window on the first documentation of
criteria and broadening the risk category of RIFLE to
include increases in serum creatinine of ≥ 0.3 mg/dL
even if this does not reach the 50% cutoff [13].
In conclusion, in these ICU patients, acute kidney risk,
injury, and failure, as defined by the recently developed
RIFLE classification, were associated with increased
186 The Korean Journal of Internal Medicine Vol. 25, No. 2, June 2010hospital mortality rates. The RIFLE classification is a
simple and useful clinical tool to detect and stratify the
severity of AKI, and possibly to predict outcome.
Conflict of interest 
No potential conflict of interest relevant to this article
was reported.
REFERENCES
1.Ympa YP, Sakr Y, Reinhart K, Vincent JL. Has mortality from
acute renal failure decreased? A systematic review of the
literature. Am J Med 2005;118:827-832. 
2. Hoste EA, Clermont G, Kersten A, et al. RIFLE criteria for acute
kidney injury are associated with hospital mortality in critically ill
patients: a cohort analysis. Crit Care 2006;10:R73.
3. Uchino S, Bellomo R, Goldsmith D, Bates S, Ronco C. An assessment
of the RIFLE criteria for acute renal failure in hospitalized
patients. Crit Care Med 2006;34:1913-1917. 
4.Uchino S, Kellum JA, Bellomo R, et al. Acute renal failure in
critically ill patients: a multinational, multicenter study. JAMA
2005;294:813-818.
5. Bellomo R, Ronco C, Kellum JA, et al. Acute renal failure -
definition, outcome measures, animal models, fluid therapy and
information technology needs: the Second International
Consensus Conference of the Acute Dialysis Quality Initiative
(ADQI) Group. Crit Care 2004;8:R204-R212. 
6.Ricci Z, Cruz D, Ronco C. The RIFLE criteria and mortality in
acute kidney injury: a systematic review. Kidney Int 2008;73:538-
546.
7. Ferreira FL, Bota DP, Bross A, Mélot C, Vincent JL. Serial evaluation
of the SOFA score to predict outcome in critically ill patients.
JAMA 2001;286:1754-1758.
8.Mehta RL, Pascual MT, Gruta CG, Zhuang S, Chertow GM.
Refining predictive models in critically ill patients with acute renal
failure. J Am Soc Nephrol 2002;13:1350-1357.
9. National Kidney Foundation. K/DOQI clinical practice guidelines
for chronic kidney disease: evaluation, classification, and
stratification. Am J Kidney Dis 2002;39:S1-S266.
10.Vincent JL, Moreno R, Takala J, et al. The Sepsis-related Organ
Failure Assessment (SOFA) score to describe organ dysfunction /
failure. On behalf of the Working Group on Sepsis-Related
Problems of the European Society of Intensive Care Medicine.
Intensive Care Med 1996;22:707-710.
11. Liaño F, Pascual J. Epidemiology of acute renal failure: a
prospective, multicenter, community-based study. Madrid Acute
Renal Failure Study Group. Kidney Int 1996;50:811-818.
12. Brivet FG, Kleinknecht DJ, Loirat P, Landais PJ. Acute renal
failure in intensive care units - causes, outcome, and prognostic
factors of hospital mortality: a prospective, multicenter study.
French Study Group on Acute Renal Failure. Crit Care Med
1996;24:192-198.
13. Mehta RL, Kellum JA, Shah SV, et al. Acute Kidney Injury
Network: report of an initiative to improve outcomes in acute
kidney injury. Crit Care 2007;11:R31.
14. Perez Valdivieso JR, Bes-Rastrollo M, Monedero P, De Irala J,
Lavilla FJ. Evaluation of the prognostic value of the risk, injury,
failure, loss and end-stage renal failure (RIFLE) criteria for acute
kidney injury. Nephrology 2008;13:361-366.
15. de Mendonça A, Vincent JL, Suter PM, et al. Acute renal failure in
the ICU: risk factors and outcome evaluated by the SOFA score.
Intensive Care Med 2000;26:915-921.
16. Klahr S, Miller SB. Acute oliguria. N Engl J Med 1998;338:671-
675.
17. Hoste EA, Kellum JA. Acute renal failure in the critically ill: impact
on morbidity and mortality. Contrib Nephrol 2004;144:1-11.
18.Abosaif NY, Tolba YA, Heap M, Russell J, El Nahas AM. The
outcome of acute renal failure in the intensive care unit according
to RIFLE: model application, sensitivity, and predictability. Am J
Kidney Dis 2005;46:1038-1048.
Park WY, et al. Risk factors and outcome of acute kidney injury     187